Liquid biopsy recently became a very promising diagnostic method that has several
advantages over conventional invasive methods. Liquid biopsy may serve as a source of …

Ovarian cancer (OC) is the sixth most common cancer in women globally. However, even
with the advances in detection and therapeutics it still represents the most dangerous …

Ovarian cancer has become the largest cause of gynaecological cancer-related mortality. It
is typically diagnosed at a late stage and has no effective screening strategy. Ovarian cancer …

Ovarian cancer is the leading cause of death among gynecologic malignancies. Since
ovarian cancer develops asymptomatically, it is often diagnosed at an advanced and …

A wealth of novel findings, including congenital ribosomal mutations in ribosomopathies and
somatic ribosomal mutations in various cancers, have significantly increased our …

Introduction: Despite advances in surgery and chemotherapy for ovarian cancer, 70% of
women still succumb to the disease. Biomarkers have contributed to the management of …

Remarkable deregulation of microRNAs has been demonstrated in epithelial ovarian cancer
(EOC). In particular, some of the let-7 miRNA family members have been proposed as tumor …

Background: Exosomes are extracellular microvesicles that are released by most cells and
widely distributed in various body fluids. Malignant cells secrete large amounts of exosomes …

Ovarian cancer is the leading cause of gynecological cancer-related death. Drug resistance
is the bottleneck in ovarian cancer treatment. The increasing use of novel drugs in clinical …

Background Risk of relapse or progression remains high in the treatment of most patients
with epithelial ovarian cancer, and development of a molecular predictor could be a …